About the Study

The study is a clinical research study investigating a potential new treatment approach for moderate to severe Crohn’s disease (CD). The study aims to determine whether the investigational study drug can be safely and effectively administered via subcutaneous injection (under the skin) instead of the traditional intravenous (IV) infusion.
Currently, many Crohn’s disease treatments require hospital-based infusions, which can be time-consuming and inconvenient. This study seeks to explore whether the study drug can induce remission—a state where Crohn’s disease symptoms significantly reduce or disappear—through an alternative delivery method that may offer more convenience to patients​.
‍
How Does the Study Work?
Induction Phase: The study drug is initially given intravenously to assess its effectiveness in helping achieve remission.
‍Maintenance Phase: If the initial phase is successful, participants will transition to a subcutaneous injection as a potential long-term treatment option.